We are live on ! Find out more
MGRX icon

Mangoceuticals

19 hedge funds and large institutions have $713K invested in Mangoceuticals in 2026 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

129% more capital inflows, than outflows

Capital inflows: $374K | Capital outflows: $163K

33% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 3

6% more funds holding

Funds holding: 18 → 19 (+1)

0.74% more ownership

Funds ownership: 6.99% → 7.73% (+0.74%)

25% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 4

Holders
19
Holders Change
+1
Holders Change %
+5.56%
% of All Funds
0.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
3
Reduced
4
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

MGRX Hedge Fund Activity: Q3 2026 in Review

19 of the 8,227 institutional investors tracked by Wall St. Rank reported a position in Mangoceuticals (MGRX) for Q3 2026, worth a combined $713K — up 57% from $456K a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new MGRX positions and 3 closed out — a net gain of 1 holder — while 3 added to existing stakes and 4 trimmed.

The largest buyer was Geode Capital Management, adding an estimated $236K. The largest seller was XTX Topco, cutting an estimated $72.7K.

  • 19 institutional investors held Mangoceuticals (MGRX) as of Q3 2026, up from 18 in Q2 2026.
  • Funds reported $713K of Mangoceuticals stock for Q3 2026, up 57% quarter-over-quarter.
  • 4 funds opened new Mangoceuticals positions in Q3 2026 and 3 closed out, a net change of +1 holder.
  • The largest Mangoceuticals buyer in Q3 2026 was Geode Capital Management, an estimated $236K added.
  • The largest Mangoceuticals seller in Q3 2026 was XTX Topco, an estimated $72.7K sold.

Based on aggregated 13F filings for Q3 2026.